Terufumi Kato

Terufumi Kato

UNVERIFIED PROFILE

Are you Terufumi Kato?   Register this Author

Register author
Terufumi Kato

Terufumi Kato

Publications by authors named "Terufumi Kato"

Are you Terufumi Kato?   Register this Author

77Publications

2036Reads

15Profile Views

Therapies after first-line afatinib in patients with m NSCLC in Japan: retrospective analysis of LUX-Lung 3.

Future Oncol 2020 Feb 10;16(4):49-60. Epub 2020 Jan 10.

Third Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0659DOI Listing
February 2020

Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti-PD-1 inhibitor.

Int J Cancer 2019 03 12;144(5):1170-1179. Epub 2018 Nov 12.

Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31923DOI Listing
March 2019

Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.

N Engl J Med 2018 11 25;379(21):2040-2051. Epub 2018 Sep 25.

From Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Universidad Complutense and Ciberonc, Madrid (L.P.-A.), and Hospital Universitario Virgen Macarena, Seville (D.V.) - both in Spain; Leningrad Regional Clinical Hospital, St. Petersburg, Russia (A.L.); Wollongong Oncology and Wollongong Private Hospital, Wollongong, NSW, Australia (A.T.); Istanbul Medeniyet University Hospital, Istanbul (M.G.), and Ankara University, Ankara (F.Ç.Ş.) - both in Turkey; Centre Hospitalier Universitaire de Toulouse, Université Paul Sabatier, Toulouse, France (J.M.); Universitätsklinikum Tübingen, Tübingen, Germany (B. Hermes); Jász-Nagykun-Szolnok County Hospital, Szolnok (T.C.), and Országos Korányi TBC és Pulmonológiai Intézet, Budapest (A.F.) - both in Hungary; Oncology Center, Medica Sur Hospital, Mexico City (J.R.-C.); Humber River Regional Hospital, Toronto (J.W.); Sendai Kousei Hospital, Sendai (S.S.), and the Kanagawa Cancer Center, Yokohama (T.K.) - both in Japan; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheong-ju, South Korea (K.H.L.); Jilin Cancer Hospital, Changchun, China (Y.C.); University of Turin, Orbassano, Italy (S.N.); Montefiore Medical Center-Albert Einstein College of Medicine, New York (B. Halmos); Merck, Kenilworth, NJ (X.L., G.M.L., B.P.); and the Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland (D.M.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1810865DOI Listing
November 2018

Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

J Clin Oncol 2017 Nov 13;35(32):3662-3670. Epub 2017 Sep 13.

Kaoru Kubota, Nippon Medical School; Kaori Hara and Takayuki Asato, Takeda Pharmaceutical, Tokyo; Hiroshige Yoshioka, Kurashiki Central Hospital, Kurashiki; Fumihiro Oshita, Kanagawa Prefectural Ashigarakami Hospital, Matsuda; Toyoaki Hida, Aichi Cancer Center Hospital, Nagoya; Kiyotaka Yoh, National Cancer Center Hospital East, Chiba; Hidetoshi Hayashi, Hiroyasu Kaneda, and Kazuhiko Nakagawa, Kindai University Faculty of Medicine; Hidetoshi Hayashi, Kishiwada Municipal Hospital, Osaka; Terufumi Kato, Kanagawa Cardiovascular and Respiratory Center, Yokohama; Kazuhiko Yamada, Kurume University School of Medicine; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hiroshi Tanaka, Niigata Cancer Center Hospital, Niigata, Japan; Keunchil Park, Samsung Biomedical Research Institute, Seoul; Eun Kyung Cho, Gachon University; Kyung-Hee Lee, Inha University Hospital, Incheon, South Korea; Chih-Bin Lin, Buddhist Tzu-Chi General Hospital, Hualien; James Chih-Hsin Yang, National Taiwan University Hospital; National Taiwan University Cancer Center, Taipei City, Peoples Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.7297DOI Listing
November 2017

Promising Effects of Afatinib on Leptomeningeal Carcinomatosis Derived from Erlotinib-resistant Lung Adenocarcinoma.

Intern Med 2016 1;55(17):2457-61. Epub 2016 Sep 1.

Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.55.6102DOI Listing
March 2017

A case of severe arthralgia with malignant mesothelioma-associated hypertrophic osteoarthropathy.

Clin Case Rep 2016 11 5;4(11):1057-1060. Epub 2016 Oct 5.

Department of Respiratory Medicine Kanagawa Cardiovascular and Respiratory Center Yokohama Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.709DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093163PMC
November 2016

[Chemotherapy in Patients Complicated with Interstitial Pneumonia].

Gan To Kagaku Ryoho 2016 Aug;43(8):945-8

Dept. of Thoracic oncology, Kanagawa Cancer Center.

View Article

Download full-text PDF

Source
August 2016

Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study.

Cancer Chemother Pharmacol 2016 Jun 29;77(6):1245-52. Epub 2016 Apr 29.

Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3040-8DOI Listing
June 2016

Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.

Lung Cancer 2016 06 30;96:63-7. Epub 2016 Mar 30.

Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.03.017DOI Listing
June 2016

Successful treatment with alectinib after crizotinib-induced interstitial lung disease.

Lung Cancer 2015 Dec 25;90(3):610-3. Epub 2015 Sep 25.

Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.09.019DOI Listing
December 2015

Promising effect of chemotherapy with bevacizumab for patients with pulmonary pleomorphic carcinoma: Two case reports and a literature review.

Respir Investig 2015 Nov 12;53(6):296-9. Epub 2015 Aug 12.

Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.resinv.2015.05.004DOI Listing
November 2015

Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy.

Med Oncol 2014 Oct 11;31(10):228. Epub 2014 Sep 11.

Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Tomioka-Higashi 6-16-1, Kanazawa-ku, Yokohama, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-014-0228-9DOI Listing
October 2014

Diffuse alveolar hemorrhage as a fatal adverse effect of bevacizumab: an autopsy case.

Jpn J Clin Oncol 2014 May 28;44(5):497-500. Epub 2014 Mar 28.

*Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Tomioka-Higashi 6-16-1, Kanazawa-ku, Yokohama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyu023DOI Listing
May 2014

Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.

J Clin Oncol 2013 Sep 1;31(27):3327-34. Epub 2013 Jul 1.

Lecia V. Sequist, Massachusetts General Hospital and Harvard Medical School, Boston, MA; James Chih-Hsin Yang, National Taiwan University Hospital; Chun-Ming Tsai, Taipei Veterans General Hospital, Taipei; Wu-Chou Su, National Cheng Kung University Hospital, Tainan, Taiwan; Nobuyuki Yamamoto, Shizuoka Cancer Center, Shizuoka; Terufumi Kato, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan; Kenneth O'Byrne, St James' Hospital, Dublin, Ireland; Vera Hirsh, McGill University, Montreal, Quebec, Canada; Tony Mok, Prince of Wales Hospital, Hong Kong, China; Sarayut Lucien Geater, Songklanagarind Hospital, Songkla, Thailand; Sergey Orlov, Pavlov State Medical University, St Petersburg; Vera Gorbunova, GU Russian Oncological Research Centre, Moscow, Russia; Michael Boyer, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Jaafar Bennouna, Institut de Cancérologie de l'Ouest-site René Gauducheau, Nantes, France; Ki Hyeong Lee, Chungbuk National University Hospital, Cheongju, South Korea; Riyaz Shah, Maidstone and Tunbridge Wells National Health Service Trust, Maidstone Hospital, Maidstone; Dan Massey, Victoria Zazulina, and Mehdi Shahidi, Boehringer Ingelheim, Bracknell, United Kingdom; and Martin Schuler, West German Cancer Center, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.2806DOI Listing
September 2013

Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice.

Respir Med 2013 Sep 9;107(9):1431-7. Epub 2013 Jul 9.

Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, 236-0051 Yokohama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2013.06.011DOI Listing
September 2013

Phase I study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer.

Jpn J Clin Oncol 2007 Mar 23;37(3):175-80. Epub 2007 Apr 23.

Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hym008DOI Listing
March 2007

[Clinical evaluation on isolation of Mycobacterium kansasii in our hospital].

Kekkaku 2004 Jul;79(7):431-5

Department of Respiratory Medicine, Tenri Hospital, Nara, Japan.

View Article

Download full-text PDF

Source
July 2004

[Pulmonary actinomycosis with recurrent hemoptysis].

Nihon Naika Gakkai Zasshi 2004 Jun;93(6):1175-7

Department of Respiratory Medicine, Tenri Hospital, Tenri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/naika.93.1175DOI Listing
June 2004

[Therapeutic drug monitoring of cyclosporine MEPC (Neoral) therapy for interstitial pneumonia].

Nihon Kokyuki Gakkai Zasshi 2004 Feb;42(2):153-7

Department of Respiratory Medicine, Tenri Hospital, 200 Mishimacho, Tenri, Nara, 632-8552, Japan.

View Article

Download full-text PDF

Source
February 2004

[A giant pulmonary aspergilloma managed surgically in an elderly man].

Nihon Kokyuki Gakkai Zasshi 2003 Oct;41(10):750-4

Department of Respiratory Medicine, Tenri Hospital, 200-Mishimacho, Tenri-shi, Nara, Japan.

View Article

Download full-text PDF

Source
October 2003

[A case of juvenile pulmonary infarction associated with diet therapy].

Nihon Kokyuki Gakkai Zasshi 2003 Mar;41(3):223-7

Department of Respiratory Medicine, Tenri Hospital, 200 Mishimacho, Tenri, Nara, 632-8552, Japan.

View Article

Download full-text PDF

Source
March 2003

[Clinical evaluation on the duration of hospitalization for patients with pulmonary tuberculosis].

Kekkaku 2003 Feb;78(2):79-82

Department of Respiratory Medicine, Tenri Hospital, 200 Mishimacho, Tenri-shi, Nara 632-8552, Japan.

View Article

Download full-text PDF

Source
February 2003

[Saprophytic mycosis appearing as a necrotic bronchial tumor and masking lung cancer].

Nihon Kokyuki Gakkai Zasshi 2003 Jan;41(1):39-43

Department of Respiratory Medicine, Tenri Hospital, 200-Mishimacho, Tenri-shi, Nara, Japan.

View Article

Download full-text PDF

Source
January 2003